Charting New Horizons: Choose Your Horizon Raises $2.6M to Revolutionize At-Home Psychiatric Care

Choose Your Horizon is excited to announce a significant milestone in our journey towards transforming mental health care—we have successfully raised $2,600,000 to further expand and enhance our innovative at-home therapies. As a leading psychiatric practice, we specialize in groundbreaking treatments such as ketamine and naltrexone, which have been carefully designed to provide compassionate and personalized care to individuals seeking relief and transformation. Our dedicated team of experienced medical professionals, specializing in psychedelic medicine, addiction recovery, and behavioral health, is deeply committed to making evidence-based mental health care accessible from the comfort of home. This new infusion of capital will allow us to broaden our reach and deepen our impact, ensuring that more people across the nation can benefit from our unique, patient-first approach to healing and growth. The funding will accelerate our mission by investing in advanced technology platforms, expanding our clinical capabilities, and enhancing patient support services. We believe that mental health care should be as individualized and accessible as possible; today’s announcement is a pivotal step in realizing that vision. Additionally, as part of our commitment to community engagement and transparency, we are proud to be participating in a Reg CF offering on StartEngine. This investment opportunity not only fuels our mission but also invites individuals to own a part of a practice that stands at the forefront of innovative mental health care. By supporting Choose Your Horizon, investors join us in our endeavor to address the escalating mental health crisis, providing hope and renewed quality of life for millions struggling with depression, anxiety, PTSD, and addiction.